DC Engage 3rd Annual Harm Reduction Conference
June 5, 2024This recorded conference content was originally presented at the 3rd annual DC Engage Harm Reduction Conference in Washington, DC. Review the content at your own pace.
The Science of Aging: Lessons for HIV at the Interface of Commonality and Heterogeneity
February 5, 2024CROI Presentation: “20 years Difference between HIV + vs HIV- in this chart’ – “These things are Happening A lot Earlier for PWH than they should be, by 20 years. I would expect 80 year olds to have this level of syndromes, but these PWH are still 60 yrs old or younger.”
HIV Clinical, Comorbid, and Social Determinants of Health are Linked with Brain Aging
Findings indicate that comorbid and social determinants of health are associated with brain aging in people with HIV, alongside traditional HIV metrics such as viral load and CD4 cell count, suggesting the need for a broadened clinical perspective on healthy aging with HIV, with additional focus on comorbidities, lifestyle changes, and social factors.
Integrating Frailty and Functional Outcomes into Clinical Trials
Considerations of frailty and functional outcomes for better integration and representation of aging patients in clinical trials.
Inflamm-aging: Effects of Chronic Inflammation with HIV
Advances in Antiretroviral therapy (ART) allow people with HIV to live longer with fewer medications. Join us as Dr. Peter Hunt details the connection between chronic inflammation and HIV infection and discusses care considerations and emerging research.
Aging With HIV Institute and Roundtable
November 9, 2021This roundtable at SYNC 2021 brought together experts living and aging with HIV (15 years or more) to review and reflect upon the current capacity and future constraints of the HIV and aging care and prevention services sectors, and the discrete needs that follow.
Aging and on PrEP: Considerations for PrEP in People 50 Years of Age and Older
October 26, 2021Ensuring older adults have access to PrEP is a key step towards ending the HIV epidemic in the U.S. This webinar presents considerations around medical, counseling, and educational strategies to improve the uptake of PrEP among people aged 50 and older. It highlights the benefits and opportunities of using PrEP in this population in efforts to decrease the rate of new HIV infections among people over 50.
A Novel Process for Determining Evidence and Impact of Retention and Re-Engagement Interventions for Dissemination
August 14, 2020This presentation discusses results from the HRSA Special Projects of National Significance Evidence-Informed Approaches to Improving Health Outcomes for people with HIV project.
